Note 2 - Acquisition of Totipotent RX (Details Textual)	1 Months Ended	12 Months Ended
	Feb. 28, 2014 USD ($) shares	Jun. 30, 2015 USD ($)	Jun. 30, 2014 USD ($)	Jun. 18, 2014 shares	Feb. 18, 2014 USD ($) shares	Jan. 30, 2014 shares
Totipotent RX Corporation [Member]
Decrease In Goodwill		$ 59,000
Number Of Wholly Owned Subsidiaries		2
Business Combination, Acquisition Related Costs			$ 1,715,000
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares | shares	12,490,841
Percentage Of Common Stock Issued To Acquiree Shareholders	38.00%
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares	61,020
Business Acquisition, Equity Interest Issued or Issuable, Value Assigned	$ 27,105,000
Business Acquisition, Number of Warrants Assumed	$ 2,004
Warrant Issued In Relation To Business Acquisition | shares	61,020
Fair Value Of Common Stock In Exchange Of Warrants Issued	$ 52,000
Settlement Of Receivables And Payables Between Merging Companies	130,000
Business Combination Acquired Gross Contractual Amounts Receivable	$ 232,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Equipment		$ 59,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt					$ 337,000
Number Of Officers Whom Repayment Of Notes Payable					2
Repayment Of Each Officer Notes Payable		75,000
Repayments of Related Party Debt		$ 150,000
Shares Issued To Satisfy Remainder Of Debt | shares					82,000
Business Combination, Acquisition Related Costs			1,958,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares				2,259,000		1,668,400
Repayments of Related Party Debt			$ 150,000